Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-04-19

AUTHORS

Massimo Breccia, Elisabetta Abruzzese, Fausto Castagnetti, Massimiliano Bonifacio, Domenica Gangemi, Federica Sorà, Alessandra Iurlo, Luigiana Luciano, Antonella Gozzini, Massimo Gentile, Monica Bocchia, Debora Luzi, Alessandro Maggi, Nicola Sgherza, Alessandro Isidori, Monica Crugnola, Patrizia Pregno, Anna Rita Scortechini, Isabella Capodanno, Michele Pizzuti, Robin Foà

ABSTRACT

Scarce information is available on the use of ponatinib as second-line treatment in chronic phase chronic myeloid leukemia (CP-CML) patients resistant and/or intolerant to prior tyrosine kinase inhibitor (TKI) therapy. We collected data from 29 CML patients, with a median age of 54 years (range 32–72). Eleven patients had received dasatinib, 15 patients received nilotinib, and 3 patients received imatinib as first-line treatment. Forty-five percent of patients started ponatinib for secondary resistance, 38% for primary resistance, 7% for severe intolerance associated to a molecular warning, 7% due to the presence of a T315I mutation, and 3% for severe intolerance. Ponatinib was started at a dose of 45 mg in 60% of patients, 30 mg in 38%, and 15 mg in 2% of patients. Overall, at a median follow-up of 12 months, 85% of treated patients improved the level of response as compared to baseline, with 10 patients achieving a deep molecular response (MR4-4.5). No thrombotic events were recorded. The dose was reduced during treatment in 2 patients due to intolerance and in 8 patients in order to reduce the cardiovascular risk. Ponatinib seems a valid second-line treatment option for chronic phase CML, in particular for patients who failed a front-line second-generation TKI due to BCR-ABL-independent mechanisms of resistance. More... »

PAGES

1577-1580

Journal

TITLE

Annals of Hematology

ISSUE

9

VOLUME

97

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00277-018-3337-2

DOI

http://dx.doi.org/10.1007/s00277-018-3337-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1103474297

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29675611


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Imidazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myeloid, Chronic-Phase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Practice Patterns, Physicians'", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyridazines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1, \u201cSapienza\u201d University, Via Benevento 6, 00161, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/grid.7841.a", 
          "name": [
            "Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1, \u201cSapienza\u201d University, Via Benevento 6, 00161, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Breccia", 
        "givenName": "Massimo", 
        "id": "sg:person.01367650334.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367650334.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "S. Eugenio Hospital, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/grid.416628.f", 
          "name": [
            "S. Eugenio Hospital, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Abruzzese", 
        "givenName": "Elisabetta", 
        "id": "sg:person.0640660424.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640660424.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Hematology \u201cL. and A. Ser\u00e0gnoli,\u201d University Hospital, University of Bologna, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.6292.f", 
          "name": [
            "Institute of Hematology \u201cL. and A. Ser\u00e0gnoli,\u201d University Hospital, University of Bologna, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Castagnetti", 
        "givenName": "Fausto", 
        "id": "sg:person.01326475234.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326475234.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Section of Hematology, University of Verona, Verona, Italy", 
          "id": "http://www.grid.ac/institutes/grid.5611.3", 
          "name": [
            "Department of Medicine, Section of Hematology, University of Verona, Verona, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bonifacio", 
        "givenName": "Massimiliano", 
        "id": "sg:person.0611231355.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611231355.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Fabrizio Spaziani Hospital, Frosinone, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Fabrizio Spaziani Hospital, Frosinone, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gangemi", 
        "givenName": "Domenica", 
        "id": "sg:person.0653234357.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653234357.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cattolica Sacro Cuore University, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/grid.8142.f", 
          "name": [
            "Cattolica Sacro Cuore University, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sor\u00e0", 
        "givenName": "Federica", 
        "id": "sg:person.01171675501.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171675501.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology Division, IRCCS Ca\u2019 Granda - Maggiore Policlinico Hospital Foundation, University of Milan, Milan, Italy", 
          "id": "http://www.grid.ac/institutes/grid.4708.b", 
          "name": [
            "Hematology Division, IRCCS Ca\u2019 Granda - Maggiore Policlinico Hospital Foundation, University of Milan, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Iurlo", 
        "givenName": "Alessandra", 
        "id": "sg:person.0707634643.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707634643.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "\u2018Federico II\u2019 University of Naples, Naples, Italy", 
          "id": "http://www.grid.ac/institutes/grid.4691.a", 
          "name": [
            "\u2018Federico II\u2019 University of Naples, Naples, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Luciano", 
        "givenName": "Luigiana", 
        "id": "sg:person.013341024504.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013341024504.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AOU Careggi, University of Firenze, Florence, Italy", 
          "id": "http://www.grid.ac/institutes/grid.24704.35", 
          "name": [
            "AOU Careggi, University of Firenze, Florence, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gozzini", 
        "givenName": "Antonella", 
        "id": "sg:person.0774300321.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774300321.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology, Cosenza, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Hematology, Cosenza, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gentile", 
        "givenName": "Massimo", 
        "id": "sg:person.0613701641.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613701641.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology, University of Siena, Siena, Italy", 
          "id": "http://www.grid.ac/institutes/grid.9024.f", 
          "name": [
            "Hematology, University of Siena, Siena, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bocchia", 
        "givenName": "Monica", 
        "id": "sg:person.01005160365.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005160365.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "S. Maria Hospital, Terni, Italy", 
          "id": "http://www.grid.ac/institutes/grid.416377.0", 
          "name": [
            "S. Maria Hospital, Terni, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Luzi", 
        "givenName": "Debora", 
        "id": "sg:person.01050765065.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050765065.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology, Taranto, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Hematology, Taranto, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maggi", 
        "givenName": "Alessandro", 
        "id": "sg:person.013666165762.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013666165762.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology, \u2018Casa Sollievo della Sofferenza\u2019 Hospital, San Giovanni Rotondo, Italy", 
          "id": "http://www.grid.ac/institutes/grid.413503.0", 
          "name": [
            "Hematology, \u2018Casa Sollievo della Sofferenza\u2019 Hospital, San Giovanni Rotondo, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sgherza", 
        "givenName": "Nicola", 
        "id": "sg:person.0705622142.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0705622142.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology, Pesaro, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Hematology, Pesaro, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Isidori", 
        "givenName": "Alessandro", 
        "id": "sg:person.01017415177.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017415177.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology, Parma University, Parma, Italy", 
          "id": "http://www.grid.ac/institutes/grid.10383.39", 
          "name": [
            "Hematology, Parma University, Parma, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Crugnola", 
        "givenName": "Monica", 
        "id": "sg:person.0731044026.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731044026.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology, Azienda Ospedaliero Universitaria Citt\u00e0 della Salute e della Scienza, Turin, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Hematology, Azienda Ospedaliero Universitaria Citt\u00e0 della Salute e della Scienza, Turin, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pregno", 
        "givenName": "Patrizia", 
        "id": "sg:person.01047731772.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047731772.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology, Ancona, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Hematology, Ancona, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Scortechini", 
        "givenName": "Anna Rita", 
        "id": "sg:person.01024360201.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024360201.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology, Arcispedale Santa Maria Nuova-IRCCS, Reggio-Emilia, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Hematology, Arcispedale Santa Maria Nuova-IRCCS, Reggio-Emilia, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Capodanno", 
        "givenName": "Isabella", 
        "id": "sg:person.01123342467.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123342467.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ematologia, Potenza, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Ematologia, Potenza, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pizzuti", 
        "givenName": "Michele", 
        "id": "sg:person.0744016320.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744016320.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1, \u201cSapienza\u201d University, Via Benevento 6, 00161, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/grid.7841.a", 
          "name": [
            "Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1, \u201cSapienza\u201d University, Via Benevento 6, 00161, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fo\u00e0", 
        "givenName": "Robin", 
        "id": "sg:person.0753276525.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753276525.11"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00277-016-2820-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041359361", 
          "https://doi.org/10.1007/s00277-016-2820-x"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-04-19", 
    "datePublishedReg": "2018-04-19", 
    "description": "Scarce information is available on the use of ponatinib as second-line treatment in chronic phase chronic myeloid leukemia (CP-CML) patients resistant and/or intolerant to prior tyrosine kinase inhibitor (TKI) therapy. We collected data from 29 CML patients, with a median age of 54\u00a0years (range 32\u201372). Eleven patients had received dasatinib, 15 patients received nilotinib, and 3 patients received imatinib as first-line treatment. Forty-five percent of patients started ponatinib for secondary resistance, 38% for primary resistance, 7% for severe intolerance associated to a molecular warning, 7% due to the presence of a T315I mutation, and 3% for severe intolerance. Ponatinib was started at a dose of 45\u00a0mg in 60% of patients, 30\u00a0mg in 38%, and 15\u00a0mg in 2% of patients. Overall, at a median follow-up of 12\u00a0months, 85% of treated patients improved the level of response as compared to baseline, with 10 patients achieving a deep molecular response (MR4-4.5). No thrombotic events were recorded. The dose was reduced during treatment in 2 patients due to intolerance and in 8 patients in order to reduce the cardiovascular risk. Ponatinib seems a valid second-line treatment option for chronic phase CML, in particular for patients who failed a front-line second-generation TKI due to BCR-ABL-independent mechanisms of resistance.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00277-018-3337-2", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1358129", 
        "issn": [
          "0939-5555", 
          "1432-0584"
        ], 
        "name": "Annals of Hematology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "9", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "97"
      }
    ], 
    "keywords": [
      "chronic phase chronic myeloid leukemia patients", 
      "second-line treatment", 
      "chronic myeloid leukemia patients", 
      "myeloid leukemia patients", 
      "severe intolerance", 
      "leukemia patients", 
      "prior tyrosine kinase inhibitor (TKI) therapy", 
      "second-line treatment option", 
      "first-line treatment", 
      "second-generation TKIs", 
      "tyrosine kinase inhibitor therapy", 
      "use of ponatinib", 
      "chronic phase CML", 
      "percent of patients", 
      "deep molecular response", 
      "kinase inhibitor therapy", 
      "real-life practice", 
      "BCR-ABL", 
      "cardiovascular risk", 
      "inhibitor therapy", 
      "median age", 
      "thrombotic events", 
      "treatment options", 
      "CML patients", 
      "primary resistance", 
      "secondary resistance", 
      "patients", 
      "T315I mutation", 
      "ponatinib", 
      "level of response", 
      "intolerance", 
      "treatment", 
      "independent mechanisms", 
      "dose", 
      "molecular response", 
      "scarce information", 
      "nilotinib", 
      "imatinib", 
      "TKIs", 
      "therapy", 
      "dasatinib", 
      "response", 
      "baseline", 
      "months", 
      "CML", 
      "age", 
      "risk", 
      "resistance", 
      "percent", 
      "options", 
      "years", 
      "mutations", 
      "levels", 
      "events", 
      "presence", 
      "mechanism", 
      "use", 
      "practice", 
      "data", 
      "information", 
      "warning", 
      "order", 
      "phase chronic myeloid leukemia (CP-CML) patients", 
      "molecular warning", 
      "valid second-line treatment option", 
      "phase CML", 
      "front-line second-generation TKI"
    ], 
    "name": "Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice", 
    "pagination": "1577-1580", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1103474297"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00277-018-3337-2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29675611"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00277-018-3337-2", 
      "https://app.dimensions.ai/details/publication/pub.1103474297"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:48", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_762.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00277-018-3337-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-018-3337-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-018-3337-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-018-3337-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-018-3337-2'


 

This table displays all metadata directly associated to this object as RDF triples.

379 TRIPLES      22 PREDICATES      108 URIs      99 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00277-018-3337-2 schema:about N11dab3d12b514b66bffe22c12b692b49
2 N1aa2968ef71c416493f5f4bd970cf665
3 N22b66bf2f5b049838f0b98f88938d8bf
4 N604f4a03c4b0442ebebbb2b8dbaac40f
5 N6210c0e664f247f4a012a71247ef9756
6 N7994130db1e3449da71c6a5575dd27a3
7 N9023733414624f3798421c6eba425bcd
8 N930ee64940d0416b8b5b6f1cc582600e
9 N98c6e7d248524ddda28aae8b8c88cfdc
10 Na534b17926184f6b9f082f308c389ca8
11 Na7c887b0a2644740a4b644a69e5fcb09
12 Na94071f516f34fceae7cb1a52e74f8aa
13 Nb68df217deab4b80b290de731b60b94a
14 Nfe2756d49de54a84a97006200089264c
15 anzsrc-for:11
16 anzsrc-for:1102
17 schema:author N6a22c9be7c9e4282b635e094e9465493
18 schema:citation sg:pub.10.1007/s00277-016-2820-x
19 schema:datePublished 2018-04-19
20 schema:datePublishedReg 2018-04-19
21 schema:description Scarce information is available on the use of ponatinib as second-line treatment in chronic phase chronic myeloid leukemia (CP-CML) patients resistant and/or intolerant to prior tyrosine kinase inhibitor (TKI) therapy. We collected data from 29 CML patients, with a median age of 54 years (range 32–72). Eleven patients had received dasatinib, 15 patients received nilotinib, and 3 patients received imatinib as first-line treatment. Forty-five percent of patients started ponatinib for secondary resistance, 38% for primary resistance, 7% for severe intolerance associated to a molecular warning, 7% due to the presence of a T315I mutation, and 3% for severe intolerance. Ponatinib was started at a dose of 45 mg in 60% of patients, 30 mg in 38%, and 15 mg in 2% of patients. Overall, at a median follow-up of 12 months, 85% of treated patients improved the level of response as compared to baseline, with 10 patients achieving a deep molecular response (MR4-4.5). No thrombotic events were recorded. The dose was reduced during treatment in 2 patients due to intolerance and in 8 patients in order to reduce the cardiovascular risk. Ponatinib seems a valid second-line treatment option for chronic phase CML, in particular for patients who failed a front-line second-generation TKI due to BCR-ABL-independent mechanisms of resistance.
22 schema:genre article
23 schema:inLanguage en
24 schema:isAccessibleForFree false
25 schema:isPartOf N12cc5db1bafc4627a8c220063611aa0e
26 N50cf15a0a58c46aebe580c1556ef41d6
27 sg:journal.1358129
28 schema:keywords BCR-ABL
29 CML
30 CML patients
31 T315I mutation
32 TKIs
33 age
34 baseline
35 cardiovascular risk
36 chronic myeloid leukemia patients
37 chronic phase CML
38 chronic phase chronic myeloid leukemia patients
39 dasatinib
40 data
41 deep molecular response
42 dose
43 events
44 first-line treatment
45 front-line second-generation TKI
46 imatinib
47 independent mechanisms
48 information
49 inhibitor therapy
50 intolerance
51 kinase inhibitor therapy
52 leukemia patients
53 level of response
54 levels
55 mechanism
56 median age
57 molecular response
58 molecular warning
59 months
60 mutations
61 myeloid leukemia patients
62 nilotinib
63 options
64 order
65 patients
66 percent
67 percent of patients
68 phase CML
69 phase chronic myeloid leukemia (CP-CML) patients
70 ponatinib
71 practice
72 presence
73 primary resistance
74 prior tyrosine kinase inhibitor (TKI) therapy
75 real-life practice
76 resistance
77 response
78 risk
79 scarce information
80 second-generation TKIs
81 second-line treatment
82 second-line treatment option
83 secondary resistance
84 severe intolerance
85 therapy
86 thrombotic events
87 treatment
88 treatment options
89 tyrosine kinase inhibitor therapy
90 use
91 use of ponatinib
92 valid second-line treatment option
93 warning
94 years
95 schema:name Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice
96 schema:pagination 1577-1580
97 schema:productId N22f9532d531049e99f5cb5696771eefc
98 N51fc09a2d0fa46c193ebc72642a186cd
99 Ned5e1ec107f6407595f106da358091f6
100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103474297
101 https://doi.org/10.1007/s00277-018-3337-2
102 schema:sdDatePublished 2022-01-01T18:48
103 schema:sdLicense https://scigraph.springernature.com/explorer/license/
104 schema:sdPublisher Nb8fd02f6b81a4114a2fc85f5771b91b4
105 schema:url https://doi.org/10.1007/s00277-018-3337-2
106 sgo:license sg:explorer/license/
107 sgo:sdDataset articles
108 rdf:type schema:ScholarlyArticle
109 N11dab3d12b514b66bffe22c12b692b49 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Retrospective Studies
111 rdf:type schema:DefinedTerm
112 N12cc5db1bafc4627a8c220063611aa0e schema:volumeNumber 97
113 rdf:type schema:PublicationVolume
114 N188c63126205496ab46a9cca3934ad1f rdf:first sg:person.0731044026.14
115 rdf:rest N1b70c795c19f4ac7975a15c6b3c37ee3
116 N1aa2968ef71c416493f5f4bd970cf665 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Pyridazines
118 rdf:type schema:DefinedTerm
119 N1b70c795c19f4ac7975a15c6b3c37ee3 rdf:first sg:person.01047731772.67
120 rdf:rest Naf25305bb92e42f99d26ebd980bc4c9e
121 N22a8daec8b1c45e8a2f119963f8a0e1e rdf:first sg:person.0653234357.40
122 rdf:rest Naf8e25f07559489ba290b102e97f521d
123 N22b66bf2f5b049838f0b98f88938d8bf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Leukemia, Myeloid, Chronic-Phase
125 rdf:type schema:DefinedTerm
126 N22f9532d531049e99f5cb5696771eefc schema:name doi
127 schema:value 10.1007/s00277-018-3337-2
128 rdf:type schema:PropertyValue
129 N2a7924b019024659b39de87295807891 rdf:first sg:person.0611231355.00
130 rdf:rest N22a8daec8b1c45e8a2f119963f8a0e1e
131 N2f05aa5e61a34b78b35c0b819f22de84 rdf:first sg:person.01050765065.93
132 rdf:rest Nc26ccc47920146cbab542ee88cf7afc3
133 N341d7194cf95436babc9efc1d4f0328d rdf:first sg:person.0774300321.37
134 rdf:rest Nb9ff99797ae34bc1996e1ff89f9ce635
135 N4d94407601d44f7a9711593c6e3d53ee rdf:first sg:person.0707634643.36
136 rdf:rest N662596e2761c4e53b55786bad44ef1fb
137 N4e349992fee042b8b6b0079f80c14552 rdf:first sg:person.0744016320.63
138 rdf:rest N7cf2afbb8f8a4b5fb95ed7351194a7d5
139 N50cf15a0a58c46aebe580c1556ef41d6 schema:issueNumber 9
140 rdf:type schema:PublicationIssue
141 N51fc09a2d0fa46c193ebc72642a186cd schema:name dimensions_id
142 schema:value pub.1103474297
143 rdf:type schema:PropertyValue
144 N5a19aa9fb569461990ebc3272a51b1d9 rdf:first sg:person.0640660424.09
145 rdf:rest N63579cfe554b43eb8a2a780f69f86444
146 N604f4a03c4b0442ebebbb2b8dbaac40f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Female
148 rdf:type schema:DefinedTerm
149 N6210c0e664f247f4a012a71247ef9756 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Dose-Response Relationship, Drug
151 rdf:type schema:DefinedTerm
152 N63579cfe554b43eb8a2a780f69f86444 rdf:first sg:person.01326475234.19
153 rdf:rest N2a7924b019024659b39de87295807891
154 N662596e2761c4e53b55786bad44ef1fb rdf:first sg:person.013341024504.85
155 rdf:rest N341d7194cf95436babc9efc1d4f0328d
156 N6a22c9be7c9e4282b635e094e9465493 rdf:first sg:person.01367650334.48
157 rdf:rest N5a19aa9fb569461990ebc3272a51b1d9
158 N7408efc46bcf401b849e8812f3d30167 rdf:first sg:person.01005160365.38
159 rdf:rest N2f05aa5e61a34b78b35c0b819f22de84
160 N7994130db1e3449da71c6a5575dd27a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Middle Aged
162 rdf:type schema:DefinedTerm
163 N7cf2afbb8f8a4b5fb95ed7351194a7d5 rdf:first sg:person.0753276525.11
164 rdf:rest rdf:nil
165 N9023733414624f3798421c6eba425bcd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Adult
167 rdf:type schema:DefinedTerm
168 N930ee64940d0416b8b5b6f1cc582600e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Practice Patterns, Physicians'
170 rdf:type schema:DefinedTerm
171 N98c6e7d248524ddda28aae8b8c88cfdc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Drug Resistance, Neoplasm
173 rdf:type schema:DefinedTerm
174 N9b7f4b7761e846e5852105ee62d52c39 rdf:first sg:person.0705622142.10
175 rdf:rest Nd927482dde594a30bdb9c7a7fba08cf7
176 Na534b17926184f6b9f082f308c389ca8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Humans
178 rdf:type schema:DefinedTerm
179 Na7c887b0a2644740a4b644a69e5fcb09 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Chemotherapy, Adjuvant
181 rdf:type schema:DefinedTerm
182 Na94071f516f34fceae7cb1a52e74f8aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Imidazoles
184 rdf:type schema:DefinedTerm
185 Nae987108c1f24447a3aa1557b5f76d58 rdf:first sg:person.01123342467.07
186 rdf:rest N4e349992fee042b8b6b0079f80c14552
187 Naf25305bb92e42f99d26ebd980bc4c9e rdf:first sg:person.01024360201.11
188 rdf:rest Nae987108c1f24447a3aa1557b5f76d58
189 Naf8e25f07559489ba290b102e97f521d rdf:first sg:person.01171675501.11
190 rdf:rest N4d94407601d44f7a9711593c6e3d53ee
191 Nb68df217deab4b80b290de731b60b94a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Aged
193 rdf:type schema:DefinedTerm
194 Nb8fd02f6b81a4114a2fc85f5771b91b4 schema:name Springer Nature - SN SciGraph project
195 rdf:type schema:Organization
196 Nb9ff99797ae34bc1996e1ff89f9ce635 rdf:first sg:person.0613701641.42
197 rdf:rest N7408efc46bcf401b849e8812f3d30167
198 Nc26ccc47920146cbab542ee88cf7afc3 rdf:first sg:person.013666165762.15
199 rdf:rest N9b7f4b7761e846e5852105ee62d52c39
200 Nd927482dde594a30bdb9c7a7fba08cf7 rdf:first sg:person.01017415177.16
201 rdf:rest N188c63126205496ab46a9cca3934ad1f
202 Ned5e1ec107f6407595f106da358091f6 schema:name pubmed_id
203 schema:value 29675611
204 rdf:type schema:PropertyValue
205 Nfe2756d49de54a84a97006200089264c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Male
207 rdf:type schema:DefinedTerm
208 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
209 schema:name Medical and Health Sciences
210 rdf:type schema:DefinedTerm
211 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
212 schema:name Cardiorespiratory Medicine and Haematology
213 rdf:type schema:DefinedTerm
214 sg:journal.1358129 schema:issn 0939-5555
215 1432-0584
216 schema:name Annals of Hematology
217 schema:publisher Springer Nature
218 rdf:type schema:Periodical
219 sg:person.01005160365.38 schema:affiliation grid-institutes:grid.9024.f
220 schema:familyName Bocchia
221 schema:givenName Monica
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005160365.38
223 rdf:type schema:Person
224 sg:person.01017415177.16 schema:affiliation grid-institutes:None
225 schema:familyName Isidori
226 schema:givenName Alessandro
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017415177.16
228 rdf:type schema:Person
229 sg:person.01024360201.11 schema:affiliation grid-institutes:None
230 schema:familyName Scortechini
231 schema:givenName Anna Rita
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024360201.11
233 rdf:type schema:Person
234 sg:person.01047731772.67 schema:affiliation grid-institutes:None
235 schema:familyName Pregno
236 schema:givenName Patrizia
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047731772.67
238 rdf:type schema:Person
239 sg:person.01050765065.93 schema:affiliation grid-institutes:grid.416377.0
240 schema:familyName Luzi
241 schema:givenName Debora
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050765065.93
243 rdf:type schema:Person
244 sg:person.01123342467.07 schema:affiliation grid-institutes:None
245 schema:familyName Capodanno
246 schema:givenName Isabella
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123342467.07
248 rdf:type schema:Person
249 sg:person.01171675501.11 schema:affiliation grid-institutes:grid.8142.f
250 schema:familyName Sorà
251 schema:givenName Federica
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171675501.11
253 rdf:type schema:Person
254 sg:person.01326475234.19 schema:affiliation grid-institutes:grid.6292.f
255 schema:familyName Castagnetti
256 schema:givenName Fausto
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326475234.19
258 rdf:type schema:Person
259 sg:person.013341024504.85 schema:affiliation grid-institutes:grid.4691.a
260 schema:familyName Luciano
261 schema:givenName Luigiana
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013341024504.85
263 rdf:type schema:Person
264 sg:person.013666165762.15 schema:affiliation grid-institutes:None
265 schema:familyName Maggi
266 schema:givenName Alessandro
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013666165762.15
268 rdf:type schema:Person
269 sg:person.01367650334.48 schema:affiliation grid-institutes:grid.7841.a
270 schema:familyName Breccia
271 schema:givenName Massimo
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367650334.48
273 rdf:type schema:Person
274 sg:person.0611231355.00 schema:affiliation grid-institutes:grid.5611.3
275 schema:familyName Bonifacio
276 schema:givenName Massimiliano
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611231355.00
278 rdf:type schema:Person
279 sg:person.0613701641.42 schema:affiliation grid-institutes:None
280 schema:familyName Gentile
281 schema:givenName Massimo
282 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613701641.42
283 rdf:type schema:Person
284 sg:person.0640660424.09 schema:affiliation grid-institutes:grid.416628.f
285 schema:familyName Abruzzese
286 schema:givenName Elisabetta
287 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640660424.09
288 rdf:type schema:Person
289 sg:person.0653234357.40 schema:affiliation grid-institutes:None
290 schema:familyName Gangemi
291 schema:givenName Domenica
292 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653234357.40
293 rdf:type schema:Person
294 sg:person.0705622142.10 schema:affiliation grid-institutes:grid.413503.0
295 schema:familyName Sgherza
296 schema:givenName Nicola
297 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0705622142.10
298 rdf:type schema:Person
299 sg:person.0707634643.36 schema:affiliation grid-institutes:grid.4708.b
300 schema:familyName Iurlo
301 schema:givenName Alessandra
302 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707634643.36
303 rdf:type schema:Person
304 sg:person.0731044026.14 schema:affiliation grid-institutes:grid.10383.39
305 schema:familyName Crugnola
306 schema:givenName Monica
307 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731044026.14
308 rdf:type schema:Person
309 sg:person.0744016320.63 schema:affiliation grid-institutes:None
310 schema:familyName Pizzuti
311 schema:givenName Michele
312 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744016320.63
313 rdf:type schema:Person
314 sg:person.0753276525.11 schema:affiliation grid-institutes:grid.7841.a
315 schema:familyName Foà
316 schema:givenName Robin
317 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753276525.11
318 rdf:type schema:Person
319 sg:person.0774300321.37 schema:affiliation grid-institutes:grid.24704.35
320 schema:familyName Gozzini
321 schema:givenName Antonella
322 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774300321.37
323 rdf:type schema:Person
324 sg:pub.10.1007/s00277-016-2820-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1041359361
325 https://doi.org/10.1007/s00277-016-2820-x
326 rdf:type schema:CreativeWork
327 grid-institutes:None schema:alternateName Ematologia, Potenza, Italy
328 Fabrizio Spaziani Hospital, Frosinone, Italy
329 Hematology, Ancona, Italy
330 Hematology, Arcispedale Santa Maria Nuova-IRCCS, Reggio-Emilia, Italy
331 Hematology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy
332 Hematology, Cosenza, Italy
333 Hematology, Pesaro, Italy
334 Hematology, Taranto, Italy
335 schema:name Ematologia, Potenza, Italy
336 Fabrizio Spaziani Hospital, Frosinone, Italy
337 Hematology, Ancona, Italy
338 Hematology, Arcispedale Santa Maria Nuova-IRCCS, Reggio-Emilia, Italy
339 Hematology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy
340 Hematology, Cosenza, Italy
341 Hematology, Pesaro, Italy
342 Hematology, Taranto, Italy
343 rdf:type schema:Organization
344 grid-institutes:grid.10383.39 schema:alternateName Hematology, Parma University, Parma, Italy
345 schema:name Hematology, Parma University, Parma, Italy
346 rdf:type schema:Organization
347 grid-institutes:grid.24704.35 schema:alternateName AOU Careggi, University of Firenze, Florence, Italy
348 schema:name AOU Careggi, University of Firenze, Florence, Italy
349 rdf:type schema:Organization
350 grid-institutes:grid.413503.0 schema:alternateName Hematology, ‘Casa Sollievo della Sofferenza’ Hospital, San Giovanni Rotondo, Italy
351 schema:name Hematology, ‘Casa Sollievo della Sofferenza’ Hospital, San Giovanni Rotondo, Italy
352 rdf:type schema:Organization
353 grid-institutes:grid.416377.0 schema:alternateName S. Maria Hospital, Terni, Italy
354 schema:name S. Maria Hospital, Terni, Italy
355 rdf:type schema:Organization
356 grid-institutes:grid.416628.f schema:alternateName S. Eugenio Hospital, Rome, Italy
357 schema:name S. Eugenio Hospital, Rome, Italy
358 rdf:type schema:Organization
359 grid-institutes:grid.4691.a schema:alternateName ‘Federico II’ University of Naples, Naples, Italy
360 schema:name ‘Federico II’ University of Naples, Naples, Italy
361 rdf:type schema:Organization
362 grid-institutes:grid.4708.b schema:alternateName Hematology Division, IRCCS Ca’ Granda - Maggiore Policlinico Hospital Foundation, University of Milan, Milan, Italy
363 schema:name Hematology Division, IRCCS Ca’ Granda - Maggiore Policlinico Hospital Foundation, University of Milan, Milan, Italy
364 rdf:type schema:Organization
365 grid-institutes:grid.5611.3 schema:alternateName Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
366 schema:name Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
367 rdf:type schema:Organization
368 grid-institutes:grid.6292.f schema:alternateName Institute of Hematology “L. and A. Seràgnoli,” University Hospital, University of Bologna, Bologna, Italy
369 schema:name Institute of Hematology “L. and A. Seràgnoli,” University Hospital, University of Bologna, Bologna, Italy
370 rdf:type schema:Organization
371 grid-institutes:grid.7841.a schema:alternateName Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1, “Sapienza” University, Via Benevento 6, 00161, Rome, Italy
372 schema:name Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1, “Sapienza” University, Via Benevento 6, 00161, Rome, Italy
373 rdf:type schema:Organization
374 grid-institutes:grid.8142.f schema:alternateName Cattolica Sacro Cuore University, Rome, Italy
375 schema:name Cattolica Sacro Cuore University, Rome, Italy
376 rdf:type schema:Organization
377 grid-institutes:grid.9024.f schema:alternateName Hematology, University of Siena, Siena, Italy
378 schema:name Hematology, University of Siena, Siena, Italy
379 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...